TrialNet Locations

With more than 200 locations offering Pathway to Prevention screening and the option to get a test kit in the mail to take to a local lab, it’s easy to participate. These Centers coordinate all the TrialNet sites in their geographical region.

Find a Location

from

Australia

Princess Margaret Hospital

Perth, WA

Led by A/Prof Elizabeth Davis, the TrialNet team at Princess Margaret Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Royal North Shore Hospital

Sydney, NSW

Led by Dr. Sally-Anne Duke, the TrialNet team at Royal North Shore Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

University of Western Sydney

Macarthur Clinical School | School of Medicine

Campbelltown, NSW

Led by Professor David Simmons, the TrialNet team at Western Sydney University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.  

Walter & Eliza Hall / Royal Melbourne Hospital

Parkville, VIC

Walter and Eliza Hall Institute of medical research in collaboration with The Royal Melbourne Hospital is one of twenty five type 1 diabetes TrialNet international clinical centres at the forefront of type 1 diabetes research. Led by Dr Peter Colman and Dr John Wentworth the TrialNet team at WEHI/RMH is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Westmead Children’s Hospital

Sydney, NSW

Led by Professor Maria Craig, the TrialNet team at Westmead Children’s Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Women’s and Children’s Hospital

Adelaide, SA

Led by Professor Jennifer Couper, the TrialNet team at Women’s and Children’s Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Pages